Tesamorelin for Muscle Growth

What Is Tesamorelin and Why Does Dosing Matter?

Tesamorelin (Synthetic GHRH analog (44 amino acid polypeptide)) is a GHRH analog, growth hormone secretagogue. Synthetic 44 amino acid GHRH analog with enhanced metabolic stability and DPP-4 protease resistance. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.

The standard research dosage for Tesamorelin has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.

What Is the Recommended Tesamorelin Dosage?

The most widely used Tesamorelin dosage is 2 mg daily, administered once daily via subcutaneous injection.

Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of Tesamorelin is 26-38 minutes, which directly determines how often you need to dose to maintain stable blood levels.

For Tesamorelin specifically, the ongoing maintenance; demonstrated benefit to 12+ months cycle length is standard. Longer isn't always better — GHRH analog, growth hormone secretagogue compounds require cycling to maintain receptor sensitivity.

When Should You Dose Tesamorelin?

With a half-life of 26-38 minutes, timing your Tesamorelin administration affects peak blood levels. Most protocols call for once daily.

For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.

How Do You Reconstitute Tesamorelin?

Tesamorelin typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.

Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.

How Long Should a Tesamorelin Cycle Last?

Standard Tesamorelin cycles run ongoing maintenance; demonstrated benefit to 12+ months. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.

Phase III 12-month trial (404 HIV patients): 18% visceral fat reduction vs placebo. Two Phase III trials confirmed VAT reduction. FDA-approved November 2010. Newest formulation Egrifta WR approved 2025.

What Side Effects Can Affect Dosing?

Well-tolerated. Injection site reactions most common. Transient flushing, headache, dizziness possible early on. No significant metabolic derangements.

If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most Tesamorelin-related side effects are dose-dependent.

How Does Tesamorelin Dosing Change When Stacking?

Combines with insulin-sensitizing agents for enhanced metabolic restoration. Off-label stacking with testosterone in HIV patients addresses complementary pathways.

When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.

What Is the Bottom Line on Tesamorelin Dosing?

Start at 2 mg daily, dose once daily, and run cycles of ongoing maintenance; demonstrated benefit to 12+ months. Monitor your response and adjust within the established range.

Source matters — always use research-grade Tesamorelin from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.

Related Reading

• Tesamorelin Benefits
• Tesamorelin Side Effects
• Tesamorelin Stacking Guide
• Tesamorelin Cycle Guide
• Tesamorelin Research
• CJC-1295 Complete Guide

Frequently Asked Questions